x

Search for a clinical trial

* (*) mandatory field

A Phase II Trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor for the treatment of patients with recurrent or refractory Ewing's Sarcoma, recurrent or refractory Osteosarcoma, Synovial Sarcoma, Rhabdomyosarcoma and other Sarcomas - DE

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Hoffmann - la roche ltd.
  • Website
  • Principal investigator of clinical trial

  • Pr Jörg T. HARTMANN
  • Klinik für Hämatologie, Onkologie und Immunologie
  • Franziskus Hospital Bielefeld
  • Kiskerstraße 26
  • 33615 BIELEFELD
  • GERMANY
  • More information
  • Phone  : 49 (0)521 589 1201
  • Fax  : 49 (0)521 589 1204
  • Website
  • Contact secretary  :
Last update: September 2015

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.